SiPhox Health

At-home biomarker blood testing

SiPhox Health builds at-home tests for biomarkers of metabolic and cardiovascular health, hormones and inflammation. With six in ten Americans living with a chronic disease, its goal is to make early detection possible without leaving home. It runs two business lines. Its mail-in blood testing service is growing more than 50 percent quarter over quarter, and an at-home blood testing device is planned for 2027. That device centres on a chip-based module that joins biochemistry with integrated photonics, electronics and microfluidics, covered by more than 50 patents. SiPhox began as an MIT startup.